IMMATICS N.V. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.21 USD | -0.49% |
|
-1.83% | -3.04% |
Chart calendar Immatics N.V.
96054248c38c2e5037b52284ce.-bR6UwlMQMwcm_ChEDzxz_BAFSdFpvGNDfqdeaMU9NE.oNgiY1E_AplS6IDQVAzGgd1yI3907JTMfZPzLdZ7mOS0gjYmPxUi_knIvQ~d6239fcdde61d17b903808b56ede0ed0
Upcoming events on Immatics N.V.
Past events on Immatics N.V.
| 2024-03-21 07:00 am | Q4 2023 Earnings Release |
| 2024-03-19 06:45 am | Bioprocessing Europe Summit |
| 2024-03-11 | Jefferies Biotech on the Bay Summit |
| 2024-03-10 | Leerink Partners Global Biopharma Conference |
| 2024-02-26 | Next Generation CAR-TCR Europe Summit |
| 2024-02-26 | Immuno-Oncology Summit |
| 2024-02-10 | Clinical Ops Executives Scope Summit |
| 2024-01-07 | J.P. Morgan Healthcare Conference |
| 2023-12-06 11:00 am | Cell Therapy Analytical Development Summit |
| 2023-12-03 | Cell Therapy Analytical Development Summit |
| 2023-11-15 03:30 am | PEGS Europe Summit |
| 2023-11-14 07:00 am | Q3 2023 Earnings Release |
| 2023-11-13 | Jefferies London Healthcare Conference |
| 2023-11-08 08:30 am | Society for Melanoma Research International Congress |
| 2023-09-25 | Jefferies Cell & Genetic Medicine Summit |
| 2023-08-27 | HW CAR-TCR Summit |
| 2023-08-17 07:00 am | Q2 2023 Earnings Release |
| 2023-08-13 | Bioprocessing Summit |
| 2023-06-20 11:30 am | CHI Immuno Oncology Summit |
| 2023-06-19 | Process Development for Cell Therapies Summit |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 20,0 | 36,8 35,1 4.78% | 38,3 62,9 -39.14% | 186 168 10.71% | 58,6 58,4 0.31% | 64,3 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -76,8 -78,7 2.36% | -89,2 -97,3 8.26% | 39,7 32,6 21.89% | -103 -96,0 -6.8% | -118 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -82,0 -83,7 1.96% | -95,0 -102 7.15% | 32,2 26,4 22% | -110 -110 -0.05% | -138 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -270 -269 -0.35% | -103 -105 2.29% | 0,00 0,00 - | -105 -114 7.24% | -151 |
|
Net income Million USD | Released Forecast Spread | 0,00 | -269 -271 0.63% | -103 -108 4.38% | 40,4 38,6 4.5% | -105 -111 4.91% | -140 |
|
EPS USD | Released Forecast Spread | -29,4 | -5,61 -6,19 9.35% | -1,63 -1,67 2.48% | 0,59 0,67 -11.06% | -1,30 -1,37 4.63% | -1,47 |
| Announcement Date | 16/04/20 | 30/03/21 | 23/03/22 | 21/03/23 | 21/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 17,3 47,9 -63.8% | 110 156 -29.16% | 17,6 24,6 -28.45% | 15,5 12,1 28.22% | 40,5 27,6 46.8% | 10,6 13,1 -18.49% | 24,4 21,7 12.63% | 6,34 11,9 -46.85% | 17,3 16,3 6.05% | 22,1 | 14,4 | 14,1 | 13,5 |
|
EBITDA Million USD | Released Forecast Spread | -28,1 -35,3 20.33% | ||||||||||||
|
EBIT Million USD | Released Forecast Spread | -17,7 -23,1 23.38% | 73,5 126 -41.81% | -17,0 -28,6 40.55% | -22,6 -27,3 17.14% | 0,05 2,64 -98.17% | -28,7 -27,8 -3.4% | -15,6 -20,6 24.16% | -35,6 -31,5 -13.01% | -30,1 -34,6 13.16% | -27,6 | -35,0 | -37,3 | -39,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -18,5 -22,1 16.45% | 91,9 132 -30.16% | -13,1 -24,7 46.84% | -21,0 -26,3 19.98% | -21,4 -20,9 -2.7% | -26,8 -31,2 13.88% | -28,3 -34,3 17.32% | -28,4 7,71 -468.03% | -35,0 | -36,6 | -34,2 | -45,7 | |
|
Net income Million USD | Released Forecast Spread | -18,5 51,0 -136.26% | 91,9 118 -21.97% | -14,3 7,84 -282.29% | -21,6 -20,7 -4.34% | -14,2 -18,2 21.76% | -21,4 -27,0 20.51% | -26,8 -25,0 -7.21% | -28,3 -33,4 15.15% | -28,4 -31,7 10.38% | -29,6 | -36,6 | -35,4 | -43,5 |
|
EPS USD | Released Forecast Spread | -0,29 -0,35 17% | 1,45 1,90 -23.61% | -0,22 -0,08 -199.77% | -0,33 -0,43 22.51% | -0,25 -0,14 -76.84% | -0,28 -0,36 20.73% | -0,35 -0,34 -1.7% | -0,34 -0,39 13.07% | -0,33 -0,40 18.04% | -0,29 | -0,35 | -0,34 | -0,42 |
| Announcement Date | 23/03/22 | 02/06/22 | 09/08/22 | 17/11/22 | 21/03/23 | 16/05/23 | 17/08/23 | 14/11/23 | 21/03/24 | - | - | - | - |
More events
Past sector events for Immatics N.V.
| 2024-04-17 | BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-04-17 | JIANGSU YAHONG MEDITECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-12 | SINOCELLTECH GROUP LIMITED: Q4 2023 Earnings Release |
| 2024-04-10 07:00 am | NURIX THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-04-08 | MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-02 03:06 am | TAIMED BIOLOGICS INC.: March 2024 Sales and Revenue Release |
| 2024-03-31 | PEPTRON, INC.: Q4 2023 Earnings Release (Projected) |
| 2024-03-31 | BIONEER CORPORATION: Q4 2023 Earnings Release (Projected) |
| 2024-03-29 08:30 am | INNOCARE PHARMA LIMITED: Q4 2023 Earnings Release |
| 2024-03-28 | BIO-THERA SOLUTIONS, LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IMTX Stock
- Calendar Immatics N.V.
